Page 3 - ப்ரிஸ்க்ரிப்ஶந் டிஜிட்டல் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரிஸ்க்ரிப்ஶந் டிஜிட்டல் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரிஸ்க்ரிப்ஶந் டிஜிட்டல் சிகிச்சை Today - Breaking & Trending Today

Global Prescription Digital Therapeutics (DTx) Market Research Insights, Latest Trends, Major Player

Search jobs
09-Feb-2021
Global Prescription Digital Therapeutics (DTx) Market Research Insights, Latest Trends, Major Players Profile, Size Estimation, COVID-19 Impact and Future Trends By 2027
DBMR has added a new report titled Global Prescription Digital Therapeutics (DTx) Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. This report covers the present scenario and the growth prospects of the global market and includes a discussion of the key vendors operating in the market. It intends to supply an entire 360-degree perspective of this market concerning cutting edge technology, key advancement, drivers and restraints and prospective trends with impact analysis. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risk and entry barriers. This Global ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , South Korea , Roche Ltd , Welldoc Inc , Solera Network , Kaia Health , Headspace Health , Teva Pharmaceutical Industries Ltd , Morrow Inc , Better Therapeutics , Market Research , Omada Health Inc , Headspace Inc , Pear Therapeutics Inc , Global Prescription Digital Therapeutics , Various Analytic , Prescription Digital Therapeutics , Pear Therapeutics , Omada Health , Sample Report , All Related Graphs , Data Bridge Market Research ,

Global Prescription Digital Therapeutics (DTx) Market Future Demand (COVID 19 Impact Analysis) & Gro

Search jobs
25-Jan-2021
Global Prescription Digital Therapeutics (DTx) Market Future Demand (COVID 19 Impact Analysis) & Growth Analysis with Forecast up to 2027
Databridgemarketresearch.com Present “Global Prescription Digital Therapeutics (DTx) Market – Industry Trends and Forecast to 2027” new report to its research database. The report first introduces the market basics like definitions, classifications, applications and industry chain overview, and then industry policies and plans, product specifications, manufacturing processes, cost structures and so on. The report highlights the change in the market which is taking place due to the moves of key players and brands such as product launches, joint ventures, mergers and acquisitions that in turns changes the view of the global face of industry. According to the report, the global market is anticipated to witness a relatively higher growth rate during the forecast ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , South Korea , Roche Ltd , Welldoc Inc , Solera Network , Kaia Health , Headspace Health , Teva Pharmaceutical Industries Ltd , Morrow Inc , Better Therapeutics , Market Research , Omada Health Inc , Headspace Inc , Pear Therapeutics Inc , Porter Five Forces Analysis , Prescription Digital Therapeutics , Industry Trends , Global Prescription Digital Therapeutics , Five Forces , Pear Therapeutics , Omada Health , Sample Report ,

Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment

News Category Global Banking & Finance Reviews
Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment
Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment
Opioid use disorder (OUD) is often an isolating experience and with COVID-19-related social distancing, fostering recovery is challenging. Recover Together, Inc. (Groups), a leading outpatient treatment provider serving individuals with OUD across eight states, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced a combined effort to treat OUD patients by providing them with Pears innovative technology as well as Groups innovative approach to treatment. ....

United States , Keely Boyer , Ba Fulton Velez , Karren Williams , Robert Gerwien , Weijia Wang , Meara Murphy , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Julia Strandberg , Hilaryf Luderer , Stephen Braun , Sam Colman , Nicole Gellings Lowe , Fultonf Velez , Alice Kuo , Journal Of Current Medical Research , Expert Review Of Pharmacoeconomics Outcomes Research , Corporate Communications , Pear Therapeutics Inc , Fdas Software Precertification Pilot Program , Pear Therapeutics , Stephanie Stitt ,

etectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics

etectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics
News provided by
Share this article
Share this article
GAINESVILLE, Fla., Jan. 14, 2021 /PRNewswire/ Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. The collaboration is the first of its kind to explore the use of digital pill solutions with PDTs.
This collaboration between etectRx and Pear Therapeutics comes at a critical time for the mental health field, an area that is in dire need of immediate solutions, said Valerie Sullivan, president and CEO of etectRx. Our goal for this collaboration is to bring concrete solutions to those who need it. ....

Corey Mccann , Caleb Liptak , Valerie Sullivan , Pear Therapeutics Inc , Cvrx Inc , Software Precertification Pilot Program , Pear Therapeutics , Central Nervous System , Prescription Digital Therapeutics , Cap System , Patient App , Clinician Dashboard , Precertification Pilot , கோரி ம்க்க்யாந் , காலேப் லிப்டக் , வலேரி சல்லிவன் , பேரிக்காய் சிகிச்சை இன்க் , ர்க்ஸ் இன்க் , பேரிக்காய் சிகிச்சை , மைய பதட்டமாக அமைப்பு , ப்ரிஸ்க்ரிப்ஶந் டிஜிட்டல் சிகிச்சை , தொப்பி அமைப்பு , நோயாளி செயலி , மருத்துவர் டாஷ்போர்டு ,

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD) |

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD)
By
Staff
4 months ago
reSET-O® is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for patients with opioid use disorder (OUD).
New economic analysis showed reSET-O to be cost-effective compared to treatment-as-usual alone over 12 weeks, and to have economic dominance when contingency management (CM) was included as part of treatment as usual.
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., today announced publication of a new economic analysis describing the cost-effectiveness of reSET-O®, the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for the treatment of opioid use disorder (OUD). The analysis, “ ....

United States , Corey Mccann , Keely Boyer , Hilaryf Luderer , Ba Fulton Velez , Stephen Braun , Karren Williams , Robert Gerwien , Sam Colman , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Fultonf Velez , Alice Kuo , Journal Of Current Medical Research , Council Of Economic Advisers , Expert Review Of Pharmacoeconomics Outcomes Research , Pear Therapeutics Inc , Food Drug Administration , Software Precertification Pilot Program , Prescription Digital Therapeutic , Pear Therapeutics , Medical Economics , Opioid Use Disorder ,